Calidi Biotherapeutics Inc

CUSIP 320703309COM NEWQ3 2025

Calidi Biotherapeutics Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

3 filings · latest May 15, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	May 15, 2025	Armistice Capital, LLC	13G	10.0%	3.36M	SEC
2	Nov 14, 2024	Polar Asset Management Partners Inc.	13G/A	—	—	SEC
3	Sep 11, 2024	Funicular Funds, LP	13G	10.0%	897.2K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Belpointe Asset Management LLC	20.8K	$31.6K
2	Osaic Holdings, Inc.	253	$149